Cardiology

145-160 of 306

Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CE
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
0.25 credits
- Pam R. Taub, MD, FACC, FASPC
- Jan T. Kielstein, MD, FASN, FERA
0.25 credits
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
- Akshay S. Desai, MD
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
- Jonathan Cunningham, MD
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
- John Ostrominski
FINE-HEART Pooled Analysis
FINE-HEART Pooled Analysis
Cardiology
FINE-HEART Pooled Analysis
- Maria Pabon, MD
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Cardiology
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
- Akshay S. Desai, MD
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Cardiology
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
- Stefan D. Anker, MD, PhD
- Mahir Karakas, MD, PhD, MBA
NYHA FC and Finerenone Response: Clinical Trial Insights
NYHA FC and Finerenone Response: Clinical Trial Insights
Cardiology
NYHA FC and Finerenone Response: Clinical Trial Insights
- John Ostrominski
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart Matters
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
- Gautam Nayak, MD
Advances in Care for ATTR-CM: Current and Emerging Strategies
Advances in Care for ATTR-CM: Current and Emerging Strategies
Heart Matters
Advances in Care for ATTR-CM: Current and Emerging Strategies
- Gautam Nayak, MD
Treating ATTR-CM: Current Strategies and Emerging Options
Treating ATTR-CM: Current Strategies and Emerging Options
Heart Matters
Treating ATTR-CM: Current Strategies and Emerging Options
- Frederick Ruberg, MD
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Heart Matters
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
- Michelle Kittleson, MD, PhD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Heart Matters
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
- Michelle Kittleson, MD, PhD
Understanding the Pathophysiology Behind ATTR-CM
Understanding the Pathophysiology Behind ATTR-CM
Heart Matters
Understanding the Pathophysiology Behind ATTR-CM
- Frederick Ruberg, MD
Cost-Effectiveness of Universal vs. Selective Screening for ATTR-CM in HFpEF Patients
Cost-Effectiveness of Universal vs. Selective Screening for ATTR-CM in HFpEF Patients
Heart Matters
Cost-Effectiveness of Universal vs. Selective Screening for ATTR-CM in HFpEF Patients
- Kibum Kim, PhD
ATTR-CM Screening: How Economic Factors Can Impact Care
ATTR-CM Screening: How Economic Factors Can Impact Care
Heart Matters
ATTR-CM Screening: How Economic Factors Can Impact Care
- Kibum Kim, PhD

10/11

145-160 of 306

Title

Welcome to Global Cardiology Academy

Welcome to Global
Cardiology Academy